NLS Pharmaceutics AG
Hedge Funds Holdings

Last updated:

NLS Pharmaceutics AG‘s stocks are currently a part of 2 hedge funds’ portfolios, which represents 0.16% of the total amount of its stocks outstanding. This makes up a total of 32.19K shares of NLS Pharmaceutics AG. Compared to the previous quarter, the number fell by -99.44% or -5.75M shares fewer. As for the holding position changes, 50% (1) of current hedge fund investors increased the number of shares held, and 50% (1) closed the holdings completely. 1 hedge funds are new holders of NLS Pharmaceutics AG stock in Q1 2023, it is 50% of total holders.

Hedge funds holding NLS Pharmaceutics AG (Q1 2021 – Q1 2023)

Number of hedge funds
Q1 2021 3
Q2 2021 4
Q3 2021 5
Q4 2021 7
Q1 2022 5
Q2 2022 4
Q3 2022 4
Q4 2022 4
Q1 2023 2

Hedge funds changes in NLS Pharmaceutics AG positions (Q1 2021 – Q1 2023)

Changes in positions
Q1 2021 30000
Q2 2021 4003-3
Q3 2021 2301-1
Q4 2021 4022-1
Q1 2022 2114-3
Q2 2022 1112-1
Q3 2022 2102-1
Q4 2022 2012-1
Q1 2023 1101-1

Top 50 hedge fund holders of NLS Pharmaceutics AG (NASDAQ:NLSP)

Hedge fund Value Shares owned Portfolio share
SUSQUEHANNA INTERNATIONAL GROUP, LLP 36K 57.48K 0.000%
RENAISSANCE TECHNOLOGIES LLC Jim Simons 16K 25.8K 0.000%
TWO SIGMA SECURITIES, LLC 11K 17.63K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 9K 14.36K 0.000%
ARMISTICE CAPITAL, LLC 0 0 0.000%
UBS GROUP AG 0 0 0.000%